Core Viewpoint - The company has not disclosed specific revenue data for the Japanese market, indicating that it is a minor part of its overseas operations and does not significantly impact overall business performance [1] Group 1 - The company stated that the Japanese market is only one component of its overseas strategy [1] - The business contribution from the Japanese market is limited [1] - Overall operations will not be decisively influenced by the performance in Japan [1]

Core Points - Aidi Te (301580.SZ) announced that major shareholders Junlian Xinkang and HAL have reduced their holdings in the company [1] - The reduction occurred between November 7, 2025, and November 12, 2025, with a total of 1,051,430 shares sold, bringing their combined holding to 9.9996% [1] - From August 21, 2025, to November 12, 2025, Junlian Xinkang and HAL sold a total of 2,907,390 shares, representing 2.7283% of the company's total equity [1] - The reduction plan has been completed ahead of schedule, and no further reductions are planned [1]

Core Viewpoint - Dosen Holdings (01580.HK) announced that its board of directors will hold a meeting on November 28, 2025, to consider and approve the unaudited performance for the six months ending September 30, 2025, and to discuss the potential distribution of dividends, if any [1] Group 1 - The board meeting is scheduled for November 28, 2025 [1] - The meeting will focus on the unaudited performance for the six months ending September 30, 2025 [1] - The board will also consider the distribution of dividends [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責，對其準確性或完整性亦 不發表任何聲明，並明確表示概不就因本公告全部或任何部分內容而產生或因倚賴該等內容而引致之任何 損失承擔任何責任。 Da Sen Holdings Group Limited 大森控股集團有限公司 ( 於開曼群島註冊成立的有限公司 ) (股份代號: 1580) 董事會會議通告 大森控股集團有限公司（「本公司」）董事會（「董事會」）謹此通告，董事會將於二零二五年 十一月二十八日（星期五）舉行董事會會議，藉以（其中包括）考慮及批准本公司及其附屬公司 截至二零二五年九月三十日止六個月之未經審核業績，以及考慮派發股息（如有）。 承董事會命 大森控股集團有限公司 公司秘書 劉仲緯 香港，二零二五年十一月十三日 於本公告日期，本公司執行董事為黃子斌先生；本公司非執行董事為梁家華博士；以及本公司獨立非執行 董事為郭耀堂先生及孫湧濤先生。 ...

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年10月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 大森控股集團有限公司 呈交日期: 2025年11月4日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01580 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.02 HKD | | | 30,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.02 HKD | | | 30,000,000 | 本月底法定/註冊 ...

Core Viewpoint - Aidi Te (301580.SZ) reported its Q3 2025 financial results, showing a total revenue of 747 million yuan and a net profit attributable to shareholders of 142 million yuan, indicating a stable financial performance in the industry [1]. Financial Performance - The company's total revenue for Q3 2025 was 747 million yuan, ranking 39th among disclosed peers [1]. - The net profit attributable to shareholders was 142 million yuan, with net cash inflow from operating activities at 141 million yuan [1]. - The latest asset-liability ratio is 11.74%, an increase of 0.23 percentage points compared to the same period last year [3]. - The gross profit margin is 52.13%, ranking 40th among disclosed peers, with a decrease of 0.79 percentage points year-on-year [3]. - The return on equity (ROE) stands at 6.79% [3]. - The diluted earnings per share (EPS) is 1.33 yuan [3]. Efficiency Metrics - The total asset turnover ratio is 0.32 times, a decrease of 0.04 times compared to the same period last year, reflecting an 11.11% year-on-year decline [4]. - The inventory turnover ratio is 2.22 times [4]. Shareholder Structure - The number of shareholders is 9,851, with the top ten shareholders holding a total of 63.65 million shares, accounting for 59.73% of the total share capital [4]. - The top ten shareholders and their respective holdings are as follows: 1. Tianjin Yuan Yi Enterprise Management Consulting Center (Limited Partnership) - 17.9% 2. Tianjin Wendi Enterprise Management Consulting Center (Limited Partnership) - 10.9% 3. Kangtuo Limited - 7.37% 4. Suzhou Junlian Xinkang Venture Capital Partnership (Limited Partnership) - 5.13% 5. CICC Qichen (Suzhou) Emerging Industry Equity Investment Fund Partnership (Limited Partnership) - 3.54% 6. Schroders Capital Private Equity Asia Hong Kong I Limited - 3.53% 7. Tianjin Jieying Enterprise Management Consulting Center (Limited Partnership) - 3.52% 8. ASP Hero SPV Limited - 3.24% 9. CITIC Securities Investment Co., Ltd. - 2.27% 10. Shanghai Jiachen Private Fund Management Co., Ltd. - 2.24% [4].

Core Viewpoint - The company's performance in the first half of 2025 meets expectations, with strong growth in overseas business. Looking ahead to Q3 and the second half of 2025, the company is actively expanding its overseas market, expecting foreign income to maintain rapid growth. In the domestic market, the company anticipates that the revenue growth rate will exceed that of 2024 through the synergistic development of chairside repair systems, implant business, and repair materials [1][4][6]. Financial Performance - In the first half of 2025, the company achieved revenue of 486 million yuan, a year-on-year increase of 17.22%, and a net profit attributable to shareholders of 92 million yuan, up 19.86%. The net profit excluding non-recurring items was 84 million yuan, reflecting a growth of 9.35% [2][4]. - For Q2 2025, the company reported revenue of 280 million yuan, a year-on-year increase of 16.61% and a quarter-on-quarter increase of 36.52%. The net profit attributable to shareholders was 61 million yuan, up 13.61% year-on-year and 94.34% quarter-on-quarter [4]. Business Segments - The core business of dental repair materials showed steady growth, with revenue of 358 million yuan in the first half of 2025, a year-on-year increase of 19.19%, accounting for 73.74% of total revenue. The revenue from digital dental equipment was 96 million yuan, up 3.64% year-on-year, representing 19.80% of total revenue [5]. - The overall gross margin for the first half of 2025 was approximately 51.94%, slightly down year-on-year. The gross margin for dental repair materials was 58.20%, down 2.17 percentage points, while the gross margin for digital dental equipment was 30.50%, up 1.24 percentage points [5]. Research and Development - The company increased its R&D investment, with R&D expenses reaching 28 million yuan, a year-on-year increase of 36.12%, representing 5.82% of revenue. This increase is attributed to the hiring of additional R&D personnel and higher costs for new product registrations [6]. Strategic Outlook - The company aims to consolidate its leading position in the dental repair materials sector and build long-term competitiveness through a "materials + equipment + implants" collaborative development strategy [7][8]. - The company is enhancing its global layout, with overseas markets becoming a significant driver of revenue growth, as evidenced by a 34% year-on-year increase in foreign income in the first half of 2025 [9]. Revenue Forecast - The company forecasts revenues of 1.034 billion yuan, 1.205 billion yuan, and 1.407 billion yuan for 2025, 2026, and 2027, respectively, representing year-on-year increases of 16.4%, 16.56%, and 16.73%. The net profit attributable to shareholders is projected to be 180 million yuan, 217 million yuan, and 262 million yuan for the same years, with growth rates of 19.33%, 20.73%, and 20.78% [10].

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2025年9月30日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 大森控股集團有限公司 呈交日期: 2025年10月3日 I. 法定/註冊股本變動 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | | 於香港聯交所上市 (註1) | | 是 | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 01580 | 說明 | | | | | | | | | | | 法定/註冊股份數目 | | | 面值 | | | 法定/註冊股本 | | | 上月底結存 | | | 1,500,000,000 | HKD | | 0.02 HKD | | | 30,000,000 | | 增加 / 減少 (-) | | | | | | HKD | | | | | 本月底結存 | | | 1,500,000,000 | HKD | | 0.02 HKD | | | 30,000,000 | 本月底法定/註冊股 ...

Da Sen Holdings Group Limited 大森控股集團有限公司 (於開曼群島註冊成立的有限公司) (股份代號: 1580) 執行董事 黃子斌先生 非執行董事 梁家華博士 獨立非執行董事 孫湧濤先生 (主席) 郭耀堂先生 董事會已成立四個委員會,而各委員會的成員載列如下：- 審核委員會 董事名單及其角色和職能 大森控股集團有限公司董事(「董事」)會(「董事會」) 成員載列如下：- 孫湧濤先生 (主席) 郭耀堂先生 薪酬委員會 孫湧濤先生 (主席) 郭耀堂先生 風險管理委員會 黃子斌先生 (主席) 郭耀堂先生 孫湧濤先生 二零二五年九月三十日 郭耀堂先生 (主席) 孫湧濤先生 提名委員會 ...

Core Viewpoint - Dazhong Holdings (01580.HK) announced that Zhang Ayang will resign from his position as an executive director at the annual general meeting of shareholders due to the failure of the resolution to re-elect him [1] Group 1 - Zhang Ayang's resignation will take effect at the conclusion of the annual general meeting [1] - The resolution to re-elect Zhang Ayang as an executive director was not passed at the shareholders' meeting [1]